For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Gaziantep 27310

0 studies enrolling now · 8 studies all time

What they study most

Diabetes Mellitus, Type 2, Genital Psoriasis, Non Small Cell Lung Cancer, Psoriasis, Rheumatoid Arthritis, Small Cell Lung Cancer, Treatment Resistant Depression

Studies at this site

• An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes — Completed
• A Moderate to Severe Rheumatoid Arthritis Study — Completed
• A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Genital Psoriasis — Completed
• A Study in Patients With Type 2 Diabetes Mellitus — Completed
• A Study of LY2963016 Compared to LANTUS® in Adult Participants With Type 2 Diabetes Mellitus — Completed
• Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer — Completed
• A Study in Relapse Prevention of Treatment-Resistant Depression — Completed
• Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung Cancer — Completed